Article
The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia.
Current pharmaceutical biotechnology - 1 Jan 2016
Forthun Rakel B, Hinrichs Carina, Dowling Tara H, Bruserud Øystein, Selheim Frode
Abstract excerpt
Acute myeloid leukemia (AML) is characterized as a heterogeneous disease where the patients are sub grouped according to several classification systems and mutational analyses. Diagnosis of AML is based on identification of the specific myeloid cell initiating the disease, quantification of immature blasts in bone marrow and peripheral blood, as well as detection of mutations and translocations. The heterogeneity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.